A Report on Non-Ionizing Radiation

Melatonin, LAN and Tamoxifen Therapy

 “Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer,” Cancer Research, posted online July 25, 2014.

Light exposure at night “may represent a unique and previously unappreciated risk factor that could account for some forms of intrinsic and possibly acquired tamoxifen resistance and may even lead to a shortened survival time and even a decreased survival rate.” From a team at Tulane University, including David Blask.